[Problems in the administration of L-DOPA (author's transl)].
D002318:Cardiovascular Diseases / Q000139:chemically induced; D003875:Drug Eruptions / Q000209:etiology; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006801:Humans; D007980:Levodopa / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D001523:Mental Disorders / Q000139:chemically induced; D009069:Movement Disorders / Q000139:chemically induced; D010300:Parkinson Disease / Q000188:drug therapy*; D014570:Urologic Diseases / Q000139:chemically induced; D014786:Vision Disorders / Q000139:chemically induced
D007980:Levodopa
Problemi posti dall'uso della L-DOPA